German Cancer-research center
The German Cancer Research Center (DKFZ) in Heidelberg is a biomedical research institution and foundation under public law . Around 3000 employees in over 90 departments and junior research groups research how cancer develops and which factors influence the cancer risk. On the basis of these results, they are developing new approaches in the prevention, diagnosis and therapy of cancer. In view of the rampant COVID-19 pandemic in Germany , the DKFZ and the German Cancer Aid Foundation and the German Cancer Society created a task force in March 2020 to provide free advice to cancer patients nationwide via their information services, Infonetz Krebs and the cancer information service KID, and to advise them on the development up to date to inform.
The DKFZ was founded in 1964 as a national research institution, the authorized representative was the Heidelberg surgeon Karl Heinrich Bauer , on whose initiative the DKFZ can be traced back. In 1975 the DKFZ became a member of the working group of large research institutions, from which the Hermann von Helmholtz Association of German Research Centers emerged in 1995 . In 1977 the DKFZ joined the German Research Foundation , in 1979 it was a founding member of the regional cooperation network Tumor Center Heidelberg / Mannheim .
The state of Baden-Württemberg is the sponsor and also bears a 10% share of the financing; the federal government is the main cost bearer with a 90% share. According to the statutes of 2000, its organs are the board of trustees (with board of directors), the scientific committee and the scientific council . Michael Baumann has been the CEO and Scientific Director since November 1, 2016 , and Josef Puchta was the Commercial Director from 1996 to 2019 . Ursula Weyrich has been Commercial Director since January 2020.
The main building of the DKFZ on the “Im Neuenheimer Feld” (INF) campus was fundamentally renovated between 2006 and 2010, 30 years after it was first occupied. The estimated cost is around 70 million euros.
In 1992 the building for applied tumor virology (INF 242) was inaugurated, and in 2002 the genome research building (INF 580) in Technology Park 3. In 2007 the German Cancer Research Center acquired the INF 581 building in Technologiepark 4.
On 6 October 2008 the longtime CEO was Harald zur Hausen for his work on human papilloma viruses of the Nobel Prize for Medicine awarded. In 2014 the physicist Stefan Hell received the Nobel Prize in Chemistry; In addition to a position at the Max Planck Institute for Biophysical Chemistry in Göttingen, Hell is also head of a department at the DKFZ.
The more than 90 departments and working groups, clinical cooperation units and junior research groups are assigned to six temporary research focuses:
- Cell and Tumor Biology
- Functional and structural genome research
- Cancer Risk Factors and Prevention
- Immunology and cancer
- Imaging and Radiation Oncology
- Infection , inflammation and cancer
According to the American model, junior research groups are linked to a “tenure track”. There are currently 25 young and six junior groups doing research at the DKFZ.
Seven central units and their services are available to all employees: genome and proteome, microscopy, information technology, chemical biology core facility, animal husbandry, library.
Doctoral students at the DKFZ receive structured training based on an interdisciplinary curriculum at the Helmholtz International Graduate School of Cancer Research.
According to the Cancer Register Ordinance, the DKFZ runs the epidemiological cancer register Baden-Württemberg in accordance with the State Cancer Register Act.
From 1966 to 1999, the research reactor TRIGA Heidelberg was operated at the DKFZ . In the summer of 2008, a 7-Tesla magnetic resonance tomograph was put into operation in a specially constructed building for research purposes .
Cooperations and alliances
- National Center for Tumor Diseases Heidelberg: The NCT Heidelberg, based on the model of the American Comprehensive Cancer Center, is supported by the German Cancer Research Center, the Heidelberg University Hospital and the German Cancer Aid . The German Cancer Aid has supported the NCT as a top oncological center since 2007 . The NCT combines interdisciplinary patient care with translational cancer research.
- DKFZ-ZMBH-Allianz: The alliance established in 2007 with the Center for Molecular Biology of the University of Heidelberg (ZMBH) is a new type of cooperation model between the non-university research center and the university.
- The Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) is a collaboration between academic science and the private sector. The aim of this "public private partnership" is to clinically test the therapeutic options that arise from stem cell research and to protect and exploit them under patent law.
- German Consortium for Translational Cancer Research (DKTK) : The German Cancer Research Center is networked nationwide with seven university partner locations (Berlin, Dresden, Essen / Düsseldorf, Frankfurt / Mainz, Freiburg, Munich and Tübingen).
- National Cancer Prevention Center: Federal Health Minister Jens Spahn and Federal Research Minister Anja Karliczek presented the National Cancer Prevention Center in September 2019, which is being set up at the German Cancer Research Center in Heidelberg as part of the “Decade against Cancer” announced by the Federal Government.
In a "strategic partnership" between the DKFZ and the German Cancer Aid Foundation , an outpatient prevention clinic for participants in prevention studies and a citizen information center are to be created, research projects are to be coordinated and bundled, and prevention programs tailored to target groups are to be developed. Krebshilfe supports the project with 25 million euros from donations.
- DKFZ-MOST (Ministry of Science and Technology [Israel]) cooperation program in cancer research (since 1976)
- Joint research units with the Institut Nationale de la Santé et de la Recherche Médicale
- Sister Institution Agreement with the MD Anderson Cancer Center, Houston, Texas (since 2008)
In addition, there are individual contacts with over 150 university and non-university research institutions abroad.
Strategic alliances with Siemens Healthineers for the development of new imaging and radiation therapy processes and with Bayer Healthcare for the development of innovative active ingredients against cancer.
Offers to the public
Cancer Information Service
With the Cancer Information Service (KID), the German Cancer Research Center has established a free, neutral and confidential information service on cancer since 1986. The offer is aimed at patients, interested parties and specialist staff. The KID website offers understandable and scientifically sound information. Trained doctors from the KID answer questions by email or on the phone (toll-free 0800-420-3040 number). The KID can be reached daily, also on weekends, from 8 a.m. to 8 p.m.
Life Science Lab
Since 2002, the DKFZ has been the sponsor of the Heidelberg Life Science Lab - a project to promote students who are particularly interested in mathematics and science.
The magazine "einblick" appears three to four times a year and can be subscribed to free of charge.
- Vincenz Czerny , founder of the Institute for Experimental Cancer Research, which is considered the predecessor of the DKFZ
- Hilke Stamatiadis-Smidt, Harald zur Hausen , Otmar D. Wiestler , Hans-Joachim Gebest (eds.): Topic cancer . Springer, Berlin 2006. 3rd edition, 263 pages. ISBN 3-540-25792-6
- Title of the old editions: Stamatiadis-Smidt, Zur Hausen (Ed.): Topic cancer . Questions and answers DKFZ KID. Springer, Berlin. 440 pages. New edition 1998 of the title Stamatiadis-Smidt, Sellschopp from 1993. ISBN 3-540-64353-2
- German Cancer Research Center (Ed.): Cancer Research Today 2006 . Steinkopff, Darmstadt 2006, 211 pages. ISBN 3-7985-1638-3
- DKFZ website
- KID - Cancer Information Service of the DKFZ
- National Center for Tumor Diseases The National Center for Tumor Diseases NCT, a cooperation project of the DKFZ
- Life Science Lab
- https://www.dkfz.de/de/presse/pressemitteilungen/2020/dkfz-pm-20-17-Trotz-Corona-Krise-Versorgung-von-Krebspatienten-sicherheitstellen.php , press release on cooperation, accessed on 2. April 2020.
- https://www.dkfz.de/de/presse/pressemitteilungen/2019/dkfz-pm-19-55-Ursula-Weyrich- DKFZ.php
- Nobel Prize Winner at the Max Planck Institute for Biophysical Chemistry in Göttingen and at the German Cancer Research Center: Stefan Hell receives Nobel Prize for Chemistry, press release no.46, October 8, 2014, accessed August 4, 2016 .
- Ultra-high-field MRI working group at the DKFZ in Heidelberg ( memento of the original from February 20, 2009 in the Internet Archive ) Info: The archive link was automatically inserted and not yet checked. Please check the original and archive link according to the instructions and then remove this notice. .
- https://www.aerzteblatt.de/nachrichten/105881/Offensive-zur-Krebspraevention , accessed on September 14, 2019
- https://www.welt.de/newsticker/news1/article200052244/Krebs-Forscher-und-Deutsche-Krebshilfe-wollen-Potenzial-der-Praevention-besser-ausschoepfen.html , accessed on September 14, 2019
- Sister Institutions of the MD Anderson Cancer Center Houston, Texas ; Retrieved July 7, 2017.
- insight - The magazine of the German Cancer Research Center